Fauna Bio, founded by three scientists, is a biotechnology company focused on revolutionizing human healthcare by leveraging the unique biological traits of animals. The company's core mission is to develop innovative treatments for human diseases such as heart disease and neurodegenerative disorders by studying mechanisms like hibernation and deep-diving in animals. Fauna Bio's platform enriches for human druggable targets across multiple disease areas, utilizing highly conserved genes and pathways identified through extensive genomics research.
Notable affiliated individuals include the founding scientists who bring deep expertise in genomics and functional biology. Fauna Bio has garnered attention from key investors in the biotech sector, contributing to its rapid progress. One of its significant achievements includes the use of high-resolution Zoonomia alignments published in Science, which has enhanced their ability to identify disease resistance mechanisms across species. Overall, Fauna Bio's innovative approach has the potential to make a substantial impact on the development of new therapies for complex human diseases.
